Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CHF 5407

Known as: CHF-5407, CHF5407 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory disease.
The use of muscarinic receptor antagonists in the treatment of chronic obstructive pulmonary disease (COPD) is well established… Expand
2010
2010
Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long…
The novel quaternary ammonium salt (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino]carbonyl]oxy]-1-[2-oxo-2-(2… Expand
  • table 1
  • table 2
  • table 3
2010
2010
CHF 5407 ) a Potent , Long-Acting and Selective Muscarinic M 3 Receptor Antagonist
The novel quaternary ammonium salt, CHF5407, showed subnanomolar affinities for human muscarinic M1, M2 and M3 receptors, and… Expand
2010
2010
Microsoft Word - 1192223-file00
The novel quaternary ammonium salt, CHF5407, showed subnanomolar affinities for human muscarinic M1, M2 and M3 receptors, and… Expand
  • table 1
  • table 2
  • table 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE